Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Diabetes Fonds | OTHER |
| dsm-firmenich Switzerland AG | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of the study is to investigate if 6 months resveratrol supplementation can improve glucose tolerance in overweight/obese individuals. As secondary objectives we want to investigate whether resting energy metabolism, intra-hepatic lipid content, physical performance, body composition and quality of life change by 6 months resveratrol supplementation in these individuals.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Resveratrol | Active Comparator | resveratrol will be given for 6 months, twice daily. One pill, which contains 75 mg of resveratrol, will be provided with lunch, and the other pill of 75 mg will be provided with dinner. So in total 150 mg/day of resveratrol will be given. |
|
| Placebo | Placebo Comparator | placebo will be given for 6 months, twice daily. One pill will be provided with lunch and the other pill will be provided with dinner. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| resveratrol | Dietary Supplement | Resveratrol will be given for 6 months, twice daily. One pill, which contains 75 mg of resveratrol, will be provided with lunch, and the other pill, also containing 75 mg will be given with dinner. So in total a dose of 150 mg/day will be given. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Glucose Tolerance | Matsuda Index calculated from double 2-hour Oral Glucose Tolerance Test (OGTT) | 2x baseline and 2x after 6 months of supplemenation |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Intra-hepatic lipid content | Intra-hepatic lipid content measured with 1H-MRS | baseline and after 6 months of supplemenation |
| Change in Resting energy expenditure | energy expenditure and substrate oxidation will be measured by an automated ventilated hood system (45 minutes) to determine whole body energy metabolism |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patrick Schrauwen, Prof. Dr. | Maastricht University Medical Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maastricht University and Medical Centre | Maastricht | Limburg | 6200 MD | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32492138 | Derived | de Ligt M, Bergman M, Fuentes RM, Essers H, Moonen-Kornips E, Havekes B, Schrauwen-Hinderling VB, Schrauwen P. No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial. Am J Clin Nutr. 2020 Oct 1;112(4):1029-1038. doi: 10.1093/ajcn/nqaa125. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018149 | Glucose Intolerance |
| D003924 | Diabetes Mellitus, Type 2 |
| D007333 | Insulin Resistance |
| D008659 | Metabolic Diseases |
| D044882 | Glucose Metabolism Disorders |
| ID | Term |
|---|---|
| D006943 | Hyperglycemia |
| D009750 | Nutritional and Metabolic Diseases |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077185 | Resveratrol |
| ID | Term |
|---|---|
| D000081225 | Stilbestrols |
| D013267 | Stilbenes |
| D001597 | Benzylidene Compounds |
| D001555 | Benzene Derivatives |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| placebo | Dietary Supplement | A placebo will given for 6 months, twice daily. One pill will be provided with lunch, and the other pill will be provided with dinner. |
|
| baseline and after 6 months of supplemenation |
| Change in Body composition | Body composition will be assessed by dual energy X-ray absorptimetry (DEXA) scan | baseline and after 6 months of supplemenation |
| Change in Blood plasma markers | Markers related to energy metabolism (for instance glucose, insulin, free fatty acids, cholesterol, glycerol and triglycerides) will be measured regularly | Once a month for a period of 6 months |
| Change in Blood pressure | blood pressure (diastolic and systolic blood pressure and heart rate) will be measured once a month | Once a month for a period of 6 months |
| Change in Physical performance | Physical performance will be assessed by the following tests: the Timed Chair Stand Test; the 6-minute walk test while they wear a MOX Activity Monitor; and a dynamometer (Biodex) will be used to determine isometric and isokinetic muscle strength of the extensor and flexor muscles of the knee joint | baseline and after 6 months of supplemenation |
| Change in Quality of life | Quality of life (QoL) will be tested using a 32-item questionnaire. This measure quantifies QoL on the dimensions Social, Spiritual, Emotional, Cognitive, Physical, Activities of Daily Living, and Integrated QoL | baseline and after 6 months of supplemenation |
| Change in Quality of sleep | Sleep quality will be measured by the 10-item Pittsburg Sleep Quality Index | baseline and after 6 months of supplemenation |
| D006946 | Hyperinsulinism |
| D006841 |
| Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D059808 | Polyphenols |
| D010636 | Phenols |